A recent ruling by the Regional Court of Düsseldorf has determined that Pfizer and its German collaborator BioNTech must compensate Moderna, assisted by Freshfields, for utilizing its European Patent 949 (EP 949), marking a significant development
A recent ruling by the Regional Court of Düsseldorf has determined that Pfizer and its German collaborator BioNTech must compensate Moderna, assisted by Freshfields, for utilizing its European Patent 949 (EP 949), marking a significant development